213 related articles for article (PubMed ID: 11235607)
1. The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
Owens D
J Assoc Physicians India; 2001 Jan; 49 Spec No():54-61. PubMed ID: 11235607
[No Abstract] [Full Text] [Related]
2. Repaglinide for type 2 diabetes mellitus.
Med Lett Drugs Ther; 1998 May; 40(1027):55-6. PubMed ID: 9618664
[No Abstract] [Full Text] [Related]
3. Repaglinide, a novel, short-acting hypoglycemic agent for type 2 diabetes mellitus.
Guay DR
Pharmacotherapy; 1998; 18(6):1195-204. PubMed ID: 9855316
[TBL] [Abstract][Full Text] [Related]
4. Current understanding regarding the role of repaglinide in post-prandial hyperglycemia.
Menon PS
J Assoc Physicians India; 2001 Jan; 49 Spec No():50-3. PubMed ID: 11235606
[No Abstract] [Full Text] [Related]
5. [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
Drug Ther Bull; 2003 Jul; 41(7):52-4. PubMed ID: 12879789
[TBL] [Abstract][Full Text] [Related]
6. [Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients].
Landgraf R
MMW Fortschr Med; 2000 Jul; 142(28-29):29-30. PubMed ID: 10959157
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.
Ambavane V; Patil R; Ainapure SS
J Postgrad Med; 2002; 48(3):246-8. PubMed ID: 12432213
[No Abstract] [Full Text] [Related]
8. Repaglinide and diabetes: new preparation. No better than glucose-lowering sulphonamides.
Prescrire Int; 2001 Feb; 10(51):9-11. PubMed ID: 11503861
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
10. Preclinical and clinical studies on safety and tolerability of repaglinide.
Schatz H
Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S144-8. PubMed ID: 10522841
[TBL] [Abstract][Full Text] [Related]
11. Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
Khamaisi M; Leitersdorf E
Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665
[TBL] [Abstract][Full Text] [Related]
12. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
[TBL] [Abstract][Full Text] [Related]
13. Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.
Khamaisi M
Diabet Med; 2012 Sep; 29(9):1214-5. PubMed ID: 22414218
[No Abstract] [Full Text] [Related]
14. Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial.
Gerstein HC; Garon J; Joyce C; Rolfe A; Walter CM
Diabet Med; 2004 Nov; 21(11):1200-3. PubMed ID: 15498086
[TBL] [Abstract][Full Text] [Related]
15. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
[TBL] [Abstract][Full Text] [Related]
16. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
17. A review of clinical experience with the prandial glucose regulator, repaglinide, in the treatment of type 2 diabetes.
Moses R
Expert Opin Pharmacother; 2000 Dec; 1(7):1455-67. PubMed ID: 11249478
[TBL] [Abstract][Full Text] [Related]
18. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?
Nattrass M; Lauritzen T
Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S21-31. PubMed ID: 11063281
[TBL] [Abstract][Full Text] [Related]
19. Repaglinide in combination therapy.
Moses R
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):33-8. PubMed ID: 12702006
[TBL] [Abstract][Full Text] [Related]
20. Repaglinide.
Balfour JA; Faulds D
Drugs Aging; 1998 Aug; 13(2):173-80. PubMed ID: 9739505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
